Global Breast Imaging Technologies Market to Reach $5.1 Billion by 2027
Amid the COVID-19 crisis, the global market for Breast Imaging Technologies estimated at US$3.2 Billion in the year 2020, is projected to reach a revised size of US$5.1 Billion by 2027, growing at aCAGR of 6.8% over the period 2020-2027. Ionizing Technologies, one of the segments analyzed in the report, is projected to record 7.3% CAGR and reach US$3.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Non-ionizing Technologies segment is readjusted to a revised 6% CAGR for the next 7-year period.
The U.S. Market is Estimated at $878.4 Million, While China is Forecast to Grow at 10.4% CAGR
The Breast Imaging Technologies market in the U.S. is estimated at US$878.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2027 trailing a CAGR of 10.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.7% and 6.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.We bring years of research experience to this 9th edition of our report. The 180-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.Competitors identified in this market include, among others,
- Aurora Imaging Technology, Inc.
- Dilon Technologies, Inc.
- FUJIFILM Holdings Corporation
- GE Healthcare
- Hologic, Inc.
- Philips Healthcare
- Siemens Healthineers
- SonoCine, Inc.
- Toshiba Corporation